GlassScriptPhysician profile
Silvia V Abreu Read
NPI 1871523886
$570.72
in general payments reported to CMS, 2019-2025
15 companies · $92.91 in 2025
The $92.91 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2023: $16.38 · 2024: $45.77 · 2025: $92.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $114.16 | 2019 | |
| Novo Nordisk INC | $60.92 | 2019-2023 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $58.40 | 2019 | |
| Medtronic, INC. | $55.71 | 2025 | Interstim |
| Takeda Pharmaceuticals U.S.A., INC. | $45.46 | 2019 | |
| Glaxosmithkline, LLC. | $42.09 | 2019-2025 | Shingrix |
| Lilly USA, LLC | $36.98 | 2019 | |
| Astellas Pharma US INC | $32.45 | 2019 | |
| Inspire Medical Systems, INC. | $24.50 | 2024 | Inspire |
| Exact Sciences Corporation | $22.61 | 2025 | Cologuard Collection Kit |
| Insmed, INC. | $21.27 | 2024 | Arikayce |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.66 | 2019 | |
| Pfizer INC. | $15.29 | 2019 | |
| Therapeuticsmd, INC. | $12.77 | 2019 | |
| Zyla Life Sciences, INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Silvia Abreu Read listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.